[Detection of drug-drug interactions in prescription between levels of health care in human immunodeficiency virus-infected patients]

Med Clin (Barc). 2014 Jan 21;142(2):92. doi: 10.1016/j.medcli.2013.06.020. Epub 2013 Sep 18.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Contraindications
  • Drug Interactions*
  • Drug Prescriptions*
  • Dyslipidemias / chemically induced*
  • Dyslipidemias / drug therapy
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Medication Errors*
  • Pharmacy Service, Hospital*
  • Primary Health Care*
  • Spain

Substances

  • HIV Protease Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors